AVIR vs HPQ · $353.7M cap vs P/E 8.6, rev $44.52B
Atea Pharmaceuticals Inc (AVIR) versus HP Inc (HPQ) — a side-by-side from cached financials, not a winner call.
Atea Pharmaceuticals Inc (AVIR) is a biotechnology company listed on US.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
AVIR does not have a complete income-statement cache yet.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
AVIR currently screens at market cap $353.7M. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Not investment advice. Open the AVIR and HPQ stock pages for the full models.
Not investment advice.